Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 3
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Articles

Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease

Anna BalcerzykDepartment of Biochemistry and Medical Genetics, Medical University of Silesia, Poland.Correspondence[email protected]
,
Iwona ZakDepartment of Biochemistry and Medical Genetics, Medical University of Silesia, Poland.
&
Jolanta KrauzeThe First Department of Cardiology, Medical University of Silesia, Katowice, Poland.
Pages 233-238 | Received 18 Jan 2007, Accepted 14 Mar 2007, Published online: 23 May 2017

References

  • Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999; 340: 115–26.
  • Carpenter KL, Taylor SE, van der Veen C, Williamson BK, Ballantine JA, Mitchinson MJ. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of devel-opment. Biochim Biophys Acta 1995; 1256: 141–50.
  • Stamler J, Daviglus ML, Garside DB, Dyer AR, Green-land P, Neaton JD. Relationship of baseline serum choles-terol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000; 284: 311–8.
  • Vasankari T, Ahotupa M, Toikka J, Mikkola J, Irjala K, Pasanen P, Neuvonen K, Raitakari 0, Viikari J. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower lev-els of oxidized LDL with statin therapy. Atherosclerosis 2001; 155: 403–12.
  • Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 2000; 153: 263–72.
  • Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Mol-huizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest Jr J, Kastelein JJ, Hayden MR. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001; 103: 1198–205.
  • Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, MR, Frick MH, Nieminen MS, Kesaniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvanne M. Peroxisome proliferator-activated receptor alpha gene vari-ants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 2002; 105: 1440–5.
  • Evans D, Beil FU. The association of the R219K polymor-phism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia. J Mol Med 2003; 81: 264–70.
  • Attie AD, Kastelein JP, Hayden MR. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res 2001; 42: 1717–26.
  • Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37: 907–25.
  • Alpert JS, Thygesen K. Myocardial infarction redefined — A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefmition of Myocardial Infarction. Eur Heart J2000; 21: 1502–13.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
  • Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996; 144: 207-13.
  • Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hay-den MR. Efflux and atherosclerosis: the clinical and bio-chemical impact of variations in the ABCA1 gene. Arte-rioscler Thromb Vasc Biol 2003; 23: 1322–32.
  • Reddy ST, Hama S, Ng C, Grijalva V, Navab M, Fogel-man AM. ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells. Arterioscler Thromb Vasc Biol 2002; 22: 1877–83.
  • Vohl MC, Lepage P, Gaudet D, Brewer CG, Betard C, Per-ron P, Houde G, Cellier C, Faith JM, Despres JP, Morgan K, Hudson TJ. Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetal-ipoproteinemia. J Lipid Res 2000; 41: 945–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.